Clinical Trials
12 trialsNCT07578337 2026-05-13
NUMANTIA-2
Nelum Corp
Phase 2 Not yet recruiting
NCT03678883 2026-04-03
9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Phase 2 Active not recruiting
NCT02250326 2024-09-19
abound2L+
Celgene
Phase 2 Completed
NCT01746225 2023-06-01
SNAP
ETOP IBCSG Partners Foundation
Phase 2 Completed
NCT03275818 2022-06-07
ABRADES
Grupo Espanol de Investigacion en Sarcomas
Phase 2 Completed
NCT02280252 2020-11-23
Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response
NYU Langone Health
Phase 2 Completed
NCT01376310 2019-02-19
GSK1120212 Rollover Study
Novartis
Phase 2 Terminated
NCT02241551 2018-07-26
Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer
University of Pittsburgh
Phase 2 Terminated
NCT01964534 2017-01-31
AFUGEM
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2 Unknown
NCT02251951 2015-10-08
Nab-Paclitaxel as Salvage Treatment in Locally Advanced or Metastatic Gastric Cancer
Hellenic Oncology Research Group
Phase 2 Completed
NCT00284752 2012-10-01
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer
Kaiser Permanente
Phase 2 Completed
NCT00466986 2011-10-12
Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer
Southeastern Gynecologic Oncology
Phase 2 Completed